4//SEC Filing
Karnani Vikram 4
Accession 0001209191-21-013382
CIK 0001492426other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:20 PM ET
Size
7.7 KB
Accession
0001209191-21-013382
Insider Transaction Report
Form 4
Karnani Vikram
SVP, Rheumatology Bus. Unit
Transactions
- Sale
Ordinary Shares
2021-02-22$88.45/sh−645$57,050→ 104,165 total - Sale
Ordinary Shares
2021-02-22$87.08/sh−7,713$671,671→ 104,810 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2020.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.71 to $87.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.14 to $88.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001699488
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:20 PM ET
- Size
- 7.7 KB